Esmotac 40 mg (Tablet (Enteric Coated))
Unit Price: ৳ 8.00 (3 x 10: ৳ 240.00)
Strip Price: ৳ 80.00
Medicine Details
Category | Details |
---|---|
Generic | Esomeprazole |
Company | Gaco pharmaceuticals ltd |
Also available as |
Indications
- Relief from chronic heartburn symptoms
- Healing of erosive esophagitis
- Maintenance of healing of erosive esophagitis
- Eradication of Helicobacter pylori infection
- Treatment of Zollinger-Ellison Syndrome
- Management of acid-related Dyspepsia
- Healing of Duodenal & Gastric ulcers
Pharmacology
- Proton pump inhibitor
- Specific inhibition of H+/K+-ATPase
- First single optical isomer of proton pump inhibitor
- Enteric-coated pellet formulation
- Peak plasma levels occur at approximately 1.5 hours after oral administration
- Extensively metabolized in the liver
- Plasma elimination half-life is approximately 1–1.5 hours
Dosage
- 20 mg or 40 mg Once Daily for 4-8 Weeks for healing of erosive esophagitis
- 20 mg Once Daily for maintenance of healing of erosive esophagitis
- 20 mg Once Daily for symptomatic GERD
- Triple Therapy for Helicobacter Pylori eradication
- 20-80 mg once daily for Zollinger-Ellison Syndrome
- 20-40 mg once daily for acid-related Dyspepsia
- 20-40 mg once daily for Duodenal & Gastric ulcers
- IV Injection or IV infusion for specific cases
Administration
- Tablet or capsule should be swallowed whole and taken one hour before a meal
- Oral Suspension preparation and administration instructions
- IV Injection solution preparation and administration guidelines
Interaction
- Extensively metabolized in the liver by CYP2C19 and CYP3A4
- Not likely to inhibit CYPs 1A2, 2A6, 2C9, 2D6, 2E1 and 3A4
- Potential interference with CYP2C19
- No clinically significant interactions with specific drugs
Contraindications
- Known hypersensitivity to any of the formulation
Side Effects
- Headache
- Diarrhoea
- Nausea
- Flatulence
- Abdominal pain
- Constipation
- Dry mouth
Pregnancy & Lactation
- No adequate and well-controlled studies in pregnant women
- Animal studies have revealed no teratogenic effects
- Excretion in milk not studied
- Breast-feeding should be discontinued if essential
Precautions & Warnings
- Symptomatic response does not preclude the presence of gastric malignancy
- Specific instructions for patients with difficulty swallowing capsules
- Antacids may be used while taking the medication
Use in Special Populations
- Safety and effectiveness in paediatric patients have not been established
- No overall differences in safety and efficacy observed between elderly and younger individuals
- Dosage adjustment for hepatic insufficiency
- Effect on patients with renal impairment
Overdose Effects
- Acute toxicity signs in animal studies
- No specific antidote known
- Treatment should be symptomatic and supportive
Storage Conditions
- Store at a temperature not exceeding 30°C in a dry place
- Protect from light and moisture
- Keep out of reach of children
Chemical Structure
- Molecular Formula: C17H19N3O3S
Common Questions
- Multiple uses of Esmotac 40 mg Tablet
- Common side effects
- Use during pregnancy or breastfeeding
- Onset of action
- Quick Tips for usage
Other
- No clinically relevant interactions with specific drugs
- Combination Therapy with Antimicrobials increases AUC and Cmax by certain percentages
Related Brands
- ESO 20 mg (Tablet (Enteric Coated)) - asiatic-laboratories-ltd
- Esocare 20 mg (Capsule (Enteric Coated)) - novelta-bestway-pharma-ltd
- Esocare 40 mg (Capsule (Enteric Coated)) - novelta-bestway-pharma-ltd
- Esocon 20 mg (Capsule (Enteric Coated)) - biopharma-limited
- Esocon 40 mg (Capsule (Enteric Coated)) - biopharma-limited